Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Genprex Inc GNPX

Healthcare Biotechnology
Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. The company’s technologies are designed to administer disease-fighting genes to provide new therapies for patient populations with cancer and diabetes. Its oncology program utilizes its systemic, non-viral Oncoprex Delivery System, which encapsulates the gene-expressing... see more

Current News (NDAQ:GNPX)

Data from Genprex's Acclaim-1 Phase 1 Gene Therapy Clinical Trial Published in Clinical Lung Cancer

PR Newswire November 24, 2025

Genprex Adds Clinical Trial Site for Acclaim-1 and Acclaim-3 Lung Cancer Clinical Trials

PR Newswire November 19, 2025

Genprex Announces U.S. Patent for Reqorsa® Gene Therapy in Combination with PD-L1 Antibodies to Treat Cancers

PR Newswire November 18, 2025

Genprex Announces European Patent Office's Intent to Grant a Patent for the Combination of Reqorsa® Gene Therapy and PD-1 Antibodies to Treat Cancer

PR Newswire November 4, 2025

Genprex Announces Registered Direct Offering of up to $10.0 Million Priced At-The-Market Under Nasdaq Rules

PR Newswire October 28, 2025

Genprex Collaborators Report Positive Preclinical Data on the Use of Reqorsa® Gene Therapy for the Treatment of Lung Cancer at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

PR Newswire October 28, 2025

Genprex Announces Registered Direct Offering of up to $8.1 Million Priced At-The-Market Under Nasdaq Rules

PR Newswire October 23, 2025

Genprex Collaborators to Present Positive Preclinical Data on the Use of Reqorsa® Gene Therapy for the Treatment of Lung Cancer at the 2025 AACR-NCI-EROTC International Conference on Molecular Targets and Cancer Therapeutics

PR Newswire October 23, 2025

Genprex Collaborators to Present Positive Preclinical Data on the Use of Reqorsa® Gene Therapy for the Treatment of Lung Cancer at the 2025 AACR-NCI-EROTC International Conference on Molecular Targets and Cancer Therapeutics

PR Newswire October 14, 2025
View More News ››

Opinion & Analysis (NDAQ:GNPX)

Genprex Shares Soar 250% on FDA Fast Track Designation for Lung Cancer Drug

Streetwise Reports January 22, 2020
View More Opinion ››

Bullboard Posts (NDAQ:GNPX)

Buy buddy buy because it's going up today.

Otherwise FOMO
coolfooldumbguy - October 28, 2025

Buy buddy buy.

Otherwise it will be FOMO time for you fellas out there today anyway
coolfooldumbguy - October 23, 2025

$GNPX News!

$GNPX @genprex Genprex Inc Announces the Appointment of Jose A. Moreno Toscano as Chairman of the Board of Directors https://www.genprex...
MasterJedijazz - May 13, 2024

GNPX ...on watch NR

No vol
Iseneschal - March 6, 2024

GNPX.... Very low volume...price action is trending higher

Looks like Mr. M is going to buy my sub $6 paper....Thanks Mr. M Cheers !
Iseneschal - February 5, 2024

GNPX....say goodbye to Hollywood

It's all over now
Iseneschal - February 5, 2024
View more Bullboard ››

Viridian Metals Inc.

Viridian Metals Inc.

Viridian Metals Inc. is a Canadian company engaged in generative exploration for critical metals, with a primary focus on ...
View More »

Podcasts